ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious LANDO Q1 2026 Earnings Preferred Stock Stays Steady With Slight EPS Beat DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline DUOT Q1 2026 Earnings Significant EPS Miss Despite Stock Rally RCKY Q1 2026 Earnings Earnings Per Share Misses Estimates Stock Declines Slightly Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377